Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$0.72 - $1.66 $5,223 - $12,043
-7,255 Reduced 38.92%
11,387 $17,000
Q4 2023

Feb 13, 2024

SELL
$0.68 - $1.31 $4,316 - $8,315
-6,348 Reduced 25.4%
18,642 $16,000
Q3 2023

Nov 14, 2023

SELL
$1.14 - $1.81 $117,305 - $186,249
-102,900 Reduced 80.46%
24,990 $33,000
Q2 2023

Aug 21, 2023

BUY
$1.79 - $4.59 $8,382 - $21,494
4,683 Added 3.8%
127,890 $228,000
Q1 2023

May 09, 2023

SELL
$2.84 - $3.92 $3,121 - $4,308
-1,099 Reduced 0.88%
123,207 $479,000
Q4 2022

Feb 14, 2023

BUY
$2.48 - $5.93 $81,160 - $194,065
32,726 Added 35.73%
124,306 $422,000
Q3 2022

Nov 18, 2022

BUY
$4.08 - $5.82 $4,479 - $6,390
1,098 Added 1.21%
91,580 $500,000
Q2 2022

Aug 15, 2022

BUY
$4.15 - $8.37 $3,075 - $6,202
741 Added 0.83%
90,482 $408,000
Q1 2022

May 16, 2022

SELL
$5.91 - $14.38 $41,115 - $100,041
-6,957 Reduced 7.19%
89,741 $661,000
Q4 2021

Feb 15, 2022

BUY
$5.21 - $8.61 $45,571 - $75,311
8,747 Added 9.95%
96,698 $622,000
Q3 2021

Nov 15, 2021

SELL
$4.45 - $10.63 $50,431 - $120,469
-11,333 Reduced 11.41%
87,951 $512,000
Q2 2021

Aug 16, 2021

SELL
$8.11 - $11.11 $52,309 - $71,659
-6,450 Reduced 6.1%
99,284 $1.03 Million
Q1 2021

May 18, 2021

SELL
$9.85 - $17.69 $3,900 - $7,005
-396 Reduced 0.37%
105,734 $1.11 Million
Q3 2020

Nov 17, 2020

BUY
$14.14 - $19.71 $5,783 - $8,061
409 Added 0.39%
106,130 $1.55 Million
Q2 2020

Aug 17, 2020

BUY
$16.6 - $25.25 $251,722 - $382,891
15,164 Added 16.75%
105,721 $2 Million
Q1 2020

May 13, 2020

SELL
$14.38 - $27.72 $6,456 - $12,446
-449 Reduced 0.49%
90,557 $1.74 Million
Q4 2019

Feb 14, 2020

SELL
$9.23 - $19.67 $5,094 - $10,857
-552 Reduced 0.6%
91,006 $1.75 Million
Q3 2019

Nov 15, 2019

BUY
$5.66 - $11.85 $14,914 - $31,224
2,635 Added 2.96%
91,558 $881,000
Q2 2019

Aug 14, 2019

BUY
$4.32 - $6.43 $56,129 - $83,544
12,993 Added 17.11%
88,923 $533,000
Q4 2018

Feb 13, 2019

BUY
$8.2 - $16.95 $14,456 - $29,882
1,763 Added 2.38%
75,930 $711,000
Q3 2018

Nov 14, 2018

SELL
$17.03 - $21.18 $442 - $550
-26 Reduced 0.04%
74,167 $1.26 Million
Q2 2018

Aug 14, 2018

BUY
$12.0 - $19.88 $240,984 - $399,230
20,082 Added 37.11%
74,193 $1.26 Million
Q1 2018

May 15, 2018

BUY
$9.92 - $17.25 $8,263 - $14,369
833 Added 1.56%
54,111 $726,000
Q4 2017

Feb 14, 2018

SELL
$9.15 - $11.99 $12,947 - $16,965
-1,415 Reduced 2.59%
53,278 $511,000
Q3 2017

Nov 13, 2017

BUY
$8.15 - $11.16 $445,747 - $610,373
54,693
54,693 $601,000

Others Institutions Holding KPTI

About Karyopharm Therapeutics Inc.


  • Ticker KPTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 79,806,600
  • Market Cap $51.1M
  • Description
  • Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...
More about KPTI
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.